Back to Search Start Over

Safety of Wolffia globosa powder as a Novel food pursuant to Regulation (EU) 2015/2283.

Authors :
Turck D
Bohn T
Castenmiller J
De Henauw S
Hirsch-Ernst KI
Maciuk A
Mangelsdorf I
McArdle HJ
Naska A
Pelaez C
Pentieva K
Siani A
Thies F
Tsabouri S
Vinceti M
Cubadda F
Frenzel T
Heinonen M
Maradona MP
Marchelli R
Neuhäuser-Berthold M
Poulsen M
Schlatter JR
van Loveren H
Kouloura E
Knutsen HK
Source :
EFSA journal. European Food Safety Authority [EFSA J] 2021 Dec 22; Vol. 19 (12), pp. e06938. Date of Electronic Publication: 2021 Dec 22 (Print Publication: 2021).
Publication Year :
2021

Abstract

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on Wolffia globosa powder as a novel food (NF) pursuant to Regulation (EU) 2015/2283. Wolffia globosa is an aquatic plant, one out of the 38 species of the water lentil family which is composed by five genera (i.e. Spirodela , Landoltia , Lemna , Wolffiella and Wolffia ). The NF is produced by cultivation of Wolffia globosa plants under controlled conditions, washing with hot water and drying. The main constituents of the NF are protein, fibre and fat. The Panel notes that the concentration of trace elements and contaminants in the NF is highly dependent on the conditions of cultivation of the plant and the fertiliser composition. The NF is intended to be used as food ingredient in a variety of food categories and as food supplement. The target population is the general population except for food supplements which are intended to be consumed exclusively by adults. The Panel considers that with the exception of concerns related to the manganese intake, taking into account the composition of the NF and the proposed conditions of use, the consumption of the NF is not nutritionally disadvantageous. The subchronic toxicity study provided with the NF revealed a number of significant findings and the Panel considers the middle dose (6.5 g/kg body weight (bw) per day) as the no observed adverse effect level (NOAEL). Based on the protein concentration, the Panel considers that the consumption of the NF may trigger allergic reactions. The Panel concluded that an increase in manganese intake from the NF used as food ingredient or food supplements is of safety concern and the safety of the NF cannot be established.<br /> (© 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.)

Details

Language :
English
ISSN :
1831-4732
Volume :
19
Issue :
12
Database :
MEDLINE
Journal :
EFSA journal. European Food Safety Authority
Publication Type :
Academic Journal
Accession number :
34987622
Full Text :
https://doi.org/10.2903/j.efsa.2021.6938